• Menopausal and cycle-related symptoms: hot flushes, PMS/PMDD, irregular cycles or concerns relating to oestrogen or progesterone balance.
• Female hormone-related concerns: endometriosis, PCOS or breast health issues monitored by a practitioner.
• Male hormone-related concerns: erectile changes, reduced muscle mass or practitioner-reviewed prostate health.
• Libido or mood symptoms: reduced sexual interest, low mood, irritability or cognitive changes.
• Metabolic and weight concerns: tendencies associated with metabolic syndrome, weight gain or altered body composition.
• Thyroid and adrenal-related symptoms: fatigue, insomnia or concerns monitored alongside thyroid function.
• Oxidative stress or chronic inflammation: practitioner-led exploration of factors contributing to long-term inflammatory or oxidative patterns.
• Family history considerations: interest in hormone-related cancers or hereditary hormonal tendencies.
• BHRT/HRT monitoring: clients using or adjusting bioidentical or conventional hormone therapy.

The Hormone and Urinary Metabolites Assessment Profile (HuMap) measures a broad range of urinary steroid hormones, their metabolites and the pathways involved in their conversion. The assessment includes oestrogens, androgens, progesterone metabolites, cortisol and cortisone metabolites, DHEA and markers that help illustrate phase I and phase II metabolic activity. The profile also includes 8-OHdG to offer additional context around oxidative stress.

Clinically, this assessment may be useful when exploring symptoms relating to menstrual health, menopause, prostate concerns, libido, mood, cognitive changes, sleep disturbances, metabolic tendencies or weight changes. Reviewing both parent hormones and downstream metabolites can help practitioners understand patterns of hormone production, clearance and balance across multiple pathways.

Practitioners often interpret these results alongside health history, nutritional intake, stress patterns, thyroid considerations, lifestyle factors and any hormone therapy in use. When viewed within this wider context, HuMap can support detailed discussion of hormone-related patterns and help inform practitioner decision-making as part of a broader functional assessment.

Specimen

Urine

Container

5 color-coded urine tubes

Patient preparation

• 24 hours prior and during collection: avoid alcohol, caffeine, tobacco or nicotine-containing products and strenuous exercise.
• Hormones may need to be discontinued for a period of time